Oruka Therapeutics, Inc. (ORKA) NASDAQ

16.18

-0.03(-0.19%)

Updated at September 18 02:07PM

Currency In USD

Oruka Therapeutics, Inc.

Address

221 Crescent Street Building 23, Suite 105

Menlo Park, MA

United States of America

Phone

203-554-7604

Sector

Healthcare

Industry

Biotechnology

Employees

28

First IPO Date

N/A

Key Executives

NameTitlePayYear Born
Dr. Lawrence Otto Klein Ph.D.President, Chief Executive Officer & Director520,9111983
Mr. Paul T. QuinlanGeneral Counsel & Secretary310,4451963
Dr. Joana Goncalves M.D.Chief Medical Officer317,9861974
Mr. Alan LadaVice President of Investor Relations0N/A
Dr. Rajiv PanwarVice President and Head of Chemistry, Manufacturing & Controls0N/A
Dr. Joe Senn Ph.D.Senior Vice President of Nonclinical Research & Development0N/A
Ms. Laura SandlerSenior Vice President of Operations & Boston Site Head0N/A
Mr. Arjun Agarwal CPASenior Vice President of Finance & Treasurer01976
Mr. Christopher FinchVice President of Corporate Development & Strategy0N/A

Description

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.